Bristol-Myers Squibb

Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
CP Wire
Bristol-Myers Squibb
Janssen
Factor XIa
stroke
Flag link:
Bristol's Opdivo-Yervoy duo snares a quick FDA nod in first-line kidney cancer
Bristol's Opdivo-Yervoy duo snares a quick FDA nod in first-line kidney cancer
Fierce Pharma
Bristol-Myers Squibb
Opdivo
Yervoy
kidney cancer
Flag link:
Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
Bristol-Myers Squibb
Janssen
Factor XIa
stroke
Flag link:
Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more
Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more
CNBC
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
non-small cell lung cancer
AACR
Flag link:
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer
Flag link:
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Forbes
Bristol-Myers Squibb
Illumina
DNA sequencing
Opdivo
diagnostics
Flag link:
With big Keytruda and Opdivo data coming at AACR, analyst hands Merck the early edge
With big Keytruda and Opdivo data coming at AACR, analyst hands Merck the early edge
Fierce Pharma
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
AACR
Flag link:
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Bloomberg
Pfizer
M&A
Bristol-Myers Squibb
Celgene
Eli Lilly
AstraZeneca
Flag link:
Trust me, Pfizer isn't interested in buying BMS, analyst says—at least not yet
Trust me, Pfizer isn't interested in buying BMS, analyst says—at least not yet
Fierce Pharma
Pfizer
M&A
Ian Read
Bristol-Myers Squibb
Flag link:
Physician payments linked to scripts for cancer drugs from Novartis, Pfizer and more: study
Physician payments linked to scripts for cancer drugs from Novartis, Pfizer and more: study
Fierce Pharma
physician payments
Novartis
Pfizer
Bayer
Bristol-Myers Squibb
cancer
Flag link:
PDUFA test
Flag link:
How a Biotech Bummer Sent Nektar Therapeutics Stock South Today
How a Biotech Bummer Sent Nektar Therapeutics Stock South Today
Motley Fool
Nektar Therapeutics
Incyte
Merck
NKTR-214
Bristol-Myers Squibb
Flag link:
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
CP Wire
metastatic non-small cell lung cancer
Altor Bioscience
ALT-803
Opdivo
Bristol-Myers Squibb
Flag link:
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
Opdivo
ALT-803
Bristol-Myers Squibb
Altor Bioscience
Flag link:
Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
Motley Fool
Big Pharma
Pharma CEOs
executive pay
AbbVie
Bristol-Myers Squibb
Gilead Sciences
JNJ
Pfizer
Flag link:
Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise
Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise
Fierce Pharma
Bristol-Myers Squibb
Pharma CEOs
Giovanni Caforio
executive pay
Flag link:
Bristol-Myers' Opdivo-Yervoy combo scores again at FDA, this time in colorectal cancer
Bristol-Myers' Opdivo-Yervoy combo scores again at FDA, this time in colorectal cancer
Fierce Pharma
Bristol-Myers Squibb
Opdivo
Yervoy
FDA
colorectal cancer
Flag link:
Lawsuit Claims Drug Abilify Causes Compulsive Gambling
Lawsuit Claims Drug Abilify Causes Compulsive Gambling
Legal Scoops
Abilify
gambling
compulsive behavior
Bristol-Myers Squibb
Otsuka
Flag link:
Why A Biopharma Buying Spree May Target AstraZeneca, Bristol
Why A Biopharma Buying Spree May Target AstraZeneca, Bristol
Investors Business Daily
AstraZeneca
Bristol-Myers Squibb
Vertex Pharmaceuticals
M&A
Flag link:
[video]How Convenience Can Give Drugmakers a Competitive Edge
[video]How Convenience Can Give Drugmakers a Competitive Edge
Motley Fool
convenience
Merck
Bristol-Myers Squibb
dosing
Opdivo
Keytruda
Flag link:

Pages